Stay updated with breaking news from Sequent Please. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the...
MILANO, Italy, Jan. 28, 2022 /PRNewswire/ -- FONDAZIONE Ricerca e Innovazione Cardiovascolare, Milano, focused on cardiovascular research, reports the first patient enrolment of the TRANSFORM II Randomized Controlled Trial (Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels) setting in motion a crucial trial in the Native Coronary Vessel Treatment domain. TRANSFORM II RCT, determined to explore and...
Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/ -- The drug-eluting balloons (DEBs) market is expected to grow by USD 476.64 million during 2020-2024, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the drug-eluting balloons (DEBs) market in optimistic, probable, and pessimistic forecast scenarios. Enterprises will go through the Response, Recovery, and Renew phases. Technavio has announced its latest market research report titled Drug Eluting Balloons Market by Product and Geography - Forecast and Analysis ...